Axsome Therapeutics (AXSM) Share-based Compensation Growth (3y) (2018 - 2026)
Powered by 
Analysis
Axsome Therapeutics (AXSM) Share-based Compensation Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 12.91% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 6.35% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 17.49% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 9.95% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 4.55% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 30.98% |
| 10 | Axsome Therapeutics | 10.72 Bn | 10.40 Bn | 204.81 Mn | 62.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.48% |
| Mar 31, 2026 | 85.64% |
| Dec 31, 2025 | 28.28% |
| Sep 30, 2025 | 52.26% |
| Jun 30, 2025 | 55.68% |
| Mar 31, 2025 | 46.46% |
| Dec 31, 2024 | 55.12% |
| Sep 30, 2024 | 55.82% |
| Jun 30, 2024 | 57.66% |
| Mar 31, 2024 | 66.35% |
| Dec 31, 2023 | 49.99% |
| Sep 30, 2023 | 61.17% |
| Jun 30, 2023 | 56.57% |
| Mar 31, 2023 | 48.37% |
| Dec 31, 2022 | 56.41% |
| Sep 30, 2022 | 27.14% |
| Jun 30, 2022 | 27.95% |
| Mar 31, 2022 | 34.82% |
| Dec 31, 2021 | 155.52% |
| Sep 30, 2021 | 27.56% |